389650 Stock Chart & Stats
₩34650.00
₩2,200.00(6.78%)
―
--
Day’s Range― - ―
52-Week Range₩30,150.00 - ₩101,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)50.99K
Market Cap
₩268.60B
Enterprise Value₩576.81K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.09
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-17.79
Shares Outstanding8,277,286
10 Day Avg. Volume38,202
30 Day Avg. Volume50,995
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
389650 FAQ
What was Nextbiomedical Co. Ltd.’s price range in the past 12 months?
Nextbiomedical Co. Ltd. lowest stock price was ₩30150.00 and its highest was ₩101000.00 in the past 12 months.
What is Nextbiomedical Co. Ltd.’s market cap?
Nextbiomedical Co. Ltd.’s market cap is ₩268.60B.
When is Nextbiomedical Co. Ltd.’s upcoming earnings report date?
Nextbiomedical Co. Ltd.’s upcoming earnings report date is Aug 13, 2026 which is in 11 days.
How were Nextbiomedical Co. Ltd.’s earnings last quarter?
Nextbiomedical Co. Ltd. released its earnings results on May 15, 2026. The company reported -₩17.788 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Nextbiomedical Co. Ltd. overvalued?
According to Wall Street analysts Nextbiomedical Co. Ltd.’s price is currently Undervalued.
Does Nextbiomedical Co. Ltd. pay dividends?
Nextbiomedical Co. Ltd. does not currently pay dividends.
What is Nextbiomedical Co. Ltd.’s EPS estimate?
Nextbiomedical Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nextbiomedical Co. Ltd. have?
Nextbiomedical Co. Ltd. has 8,277,286 shares outstanding.
What happened to Nextbiomedical Co. Ltd.’s price movement after its last earnings report?
Nextbiomedical Co. Ltd. reported an EPS of -₩17.788 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.324%.
Which hedge fund is a major shareholder of Nextbiomedical Co. Ltd.?
Currently, no hedge funds are holding shares in KR:389650
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hans Biomed Corp
―
EuBiologics Co., Ltd.
―
Genomictree, Inc.
―
HUONS CO., LTD
―
IMBiologics Corp.
―